In Attention deficit hyperactivity disorder (ADHD) Attention deficit hyperactivity disorder (ADHD) is a disorder that makes a person impulsive, restless, creates difficulty in concentrating or paying attention, and leads to behavioural issues. Ritazral Hynidate 20mg Tablet helps you improve these symptoms, making you more alert, energetic, and focused. It is the most effective medicine for treating ADHD. It improves your behavior and enhances the quality of life.
Ritazral Hynidate 20mg Tablet may cause excessive drowsiness with alcohol.
Ritazral Hynidate 20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ritazral Hynidate 20mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Ritazral Hynidate 20mg Tablet may cause side effects which could affect your ability to drive. You may feel dizzy, have problems focussing or have blurred vision when taking Ritazral Hynidate 20mg Tablet. This may affect your driving ability.
There is limited information available on the use of Ritazral Hynidate 20mg Tablet in patients with kidney disease. Please consult your doctor. Caution should be exercised in patients with underlying kidney disease.
There is limited information available on the use of Ritazral Hynidate 20mg Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Ritazral Hynidate 20mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Taj Pharma India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alteus Biogenics Pvt Ltd || ₹14.5/tablet (25% cheaper)